Xenetic Biosciences, Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:XBIO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 5.79 M5.35 M5.07 M8.36 M7.91 M Total liabilities 667.93 K903.43 K1.11 M968.02 K958.24 K Total equity 5.12 M4.45 M3.96 M7.4 M6.95 M Total liabilities & shareholders' equities 5.79 M5.35 M5.07 M8.36 M7.91 M Total debt ————— Net debt —————

News

Xenetic Biosciences extends collaboration with Scripps Research

Amneal Pharmaceuticals (AMRX) Beats Q3 Earnings and Revenue Estimates

Micron, Galecto And Xenetic Lead This Week's Benzinga Stock Ranking Surges - Galecto (NASDAQ:GLTO), Micron Technology (NASDAQ:MU), Xenetic Biosciences (NASDAQ:XBIO)

Xenetic Biosciences prices $4.5 million common stock offering

4 Stocks In The Same Sector Just Made A Huge Leap In Momentum Rankings - Galecto (NASDAQ:GLTO)

Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Apogee Therapeutics (NASDAQ:APGE), Ambow Education Holding (AMEX:AMBO)

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.00%

Nasdaq Gains 150 Points; US Mortgage Applications Decline - AlphaTON Capital (NASDAQ:ATON), Envoy Medical (NASDAQ:COCH)

Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Acurx Pharmaceuticals (NASDAQ:ACXP), AlphaTON Capital (NASDAQ:ATON)

Xenetic Biosciences (XBIO) Reports Q2 Loss, Misses Revenue Estimates

Xenetic announces clinical study of DNase I with CAR T therapy

Xenetic expands DNase-I collaboration with Scripps Research